Max Bittrich
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 20
- Multiple Myeloma Research and Treatments 18
- Hematopoietic Stem Cell Transplantation 2
- Oncology 4
- Bone health and treatments 2
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Antonio Giovanni Solimando (7 shared papers)Hermann Einsele (12 shared papers)Markus Krebs (5 shared papers)Andreas Rosenwald (2 shared papers)Andreas Beilhack (4 shared papers)Klaus Martin Kortüm (9 shared papers)Stefan Tobias Knop (5 shared papers)Thorsten Stühmer (2 shared papers)
In The Last Decade
Max Bittrich
30 papers receiving 410 citations
Peers
Comparison fields: 5 of 48
- Hematology 207
- Oncology 65
- Urology 18
- Immunology 30
- Immunology and Allergy 5
Countries citing papers authored by Max Bittrich
This map shows the geographic impact of Max Bittrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Bittrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Bittrich more than expected).
Fields of papers citing papers by Max Bittrich
This network shows the impact of papers produced by Max Bittrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Bittrich. The network helps show where Max Bittrich may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Bittrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 60 | |
| 2 | 2021 | 41 | |
| 3 | 2021 | 39 | |
| 4 | 2015 | 38 | |
| 5 | 2022 | 30 | |
| 6 | 2020 | 27 | |
| 7 | 2020 | 24 | |
| 8 | 2022 | 20 | |
| 9 | 2018 | 14 | |
| 10 | 2020 | 14 | |
| 11 | 2022 | 14 | |
| 12 | 2018 | 12 | |
| 13 | 2019 | 12 | |
| 14 | 2022 | 12 | |
| 15 | 2020 | 11 | |
| 16 | 2021 | 7 | |
| 17 | 2018 | 6 | |
| 18 | 2020 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2023 | 4 |
About Max Bittrich
Max Bittrich is a scholar working on Hematology, Oncology, Ophthalmology, Urology and Health Information Management, having authored 31 papers that have together received 419 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Biomedical Text Mining and Ontologies (2 papers), Bone health and treatments (2 papers), Drug-Induced Ocular Toxicity (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Electronic Health Records Systems (1 paper), Health Services Management and Policy (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Hematology (207 citations), Oncology (65 citations), Urology (18 citations), Immunology (30 citations) and Immunology and Allergy (5 citations). Max Bittrich has collaborated with scholars based in Germany, Italy and Spain. Frequent co-authors include Antonio Giovanni Solimando, Hermann Einsele, Markus Krebs, Andreas Rosenwald, Andreas Beilhack, Klaus Martin Kortüm, Stefan Tobias Knop, Thorsten Stühmer, Alexander Kerscher and Sophia Danhof. Their work appears in journals such as Blood, International Journal of Molecular Sciences, Journal of Cancer Research and Clinical Oncology, American Journal of Hematology and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.